Trials / Completed
CompletedNCT06368362
Cognitive Bias Modification for Interpretation Individuals With Chronic Musculoskeletal Pain
The Effectiveness and Mediators of Cognitive Bias Modification for Interpretation in the Reduction of Negative Emotional Response to Pain in Individuals With Chronic Musculoskeletal Pain
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 84 (actual)
- Sponsor
- University of Southampton · Academic / Other
- Sex
- All
- Age
- 18 Years – 70 Years
- Healthy volunteers
- Accepted
Summary
Cognitive Bias Modification for Interpretation (CBM-I) trains participants to interpret ambiguous information as neutral or benign, rather than interpret it as being related to pain. The goal of this randomised controlled trial was to explore the feasibility and potential clinical benefits of CBM-I in people with chronic pain and also healthy, pain-free individuals.
Detailed description
This study investigated whether Cognitive Bias Modification for Interpretation (CBM-I) could reduce negative emotional response to pain and to pain-related images, and whether reductions in interpretation bias (IB) and fear of pain mediated this effect. Participants with chronic musculoskeletal pain (N = 41) were randomised to benign CBM-I or no CBM-I, and healthy participants (N = 41) were randomised to benign CBM-I or pain-related CBM-I. After CBM-I, the study assessed pain-related IB and fear of pain, as well as negative emotional response to exercise-induced pain and images of musculoskeletal pain.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| BEHAVIORAL | Benign cognitive bias modification for interpretation | Benign cognitive Bias Modification for Interpretation (CBM-I) trains participants to interpret ambiguous information as neutral or benign rather than pain-related. |
| BEHAVIORAL | Pain-related cognitive bias modification for interpretation | Pain-related cognitive Bias Modification for Interpretation (CBM-I) trains participants to interpret ambiguous information as pain-related. |
Timeline
- Start date
- 2020-11-17
- Primary completion
- 2021-05-01
- Completion
- 2021-05-01
- First posted
- 2024-04-16
- Last updated
- 2024-04-16
Locations
1 site across 1 country: United Kingdom
Source: ClinicalTrials.gov record NCT06368362. Inclusion in this directory is not an endorsement.